Sign in Pull a receipt

TARA

Protara Therapeutics, Inc.

Healthcare · Biotechnology

$151.81 sample

+2.48 (+1.66%) 1D

Market cap

$847.7B

Price as of

2026-10-29

Latest filing

8-K

Alerts

8

Price$151.81 +9.84% 3M daily closessample

152.72137.33

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 26INSInsider sell: Chief Financial Officer
Oct 15INSInsider sell: EVP, Operations
Oct 08INSInsider buy: EVP, Operations
Oct 01INSInsider buy: General Counsel
Sep 22INSInsider sell: Director
Sep 14INSInsider buy: Director
Sep 03INSInsider sell: EVP, Operations
Aug 27INSInsider sell: Chief Executive Officer

Sign up to see the real TARA record →

Company facts

SEC EDGAR registration

Name: Protara Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +1sample, -100 to +100
Reporting currency: USD

Who is positioning in TARA

sample

Insiders: 23 insider transactions over 90 days, net selling, $306.5M
Congress: No member trades over 90 days
Institutions · 13F: 33 funds hold $17.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$22.6B +16.4% y/y

Q4 2024Q3 2026

Inventory$13.2B +9.7% y/y

Q4 2024Q3 2026

Accounts receivable$10.2B +16.4% y/y

Q4 2024Q3 2026

Total debt$27.6B +15.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $387.9B +3.6% 3M
Sample peer B: $635.8B -2.4% 3M
Sample peer C: $836.1B -5.9% 3M
Sample peer D: $143.4B +16.1% 3M
Sample peer E: $699.4B -10.8% 3M